93 related articles for article (PubMed ID: 14745060)
1. Peripheral blood leukocyte NO production in MS patients with a benign vs progressive course.
Ramsaransing GS; Teelken A; Arutjunyan AV; De Keyser J
Neurology; 2004 Jan; 62(2):239-42. PubMed ID: 14745060
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis.
Koch M; Ramsaransing GS; Arutjunyan AV; Stepanov M; Teelken A; Heersema DJ; De Keyser J
J Neurol; 2006 Apr; 253(4):483-7. PubMed ID: 16283096
[TBL] [Abstract][Full Text] [Related]
3. Serum uric acid levels and leukocyte nitric oxide production in multiple sclerosis patients outside relapses.
Mostert JP; Ramsaransing GS; Heersema DJ; Heerings M; Wilczak N; De Keyser J
J Neurol Sci; 2005 Apr; 231(1-2):41-4. PubMed ID: 15792819
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood leukocyte NO production and oxidative stress in multiple sclerosis.
Koch M; Mostert J; Arutjunyan A; Stepanov M; Teelken A; Heersema D; De Keyser J
Mult Scler; 2008 Mar; 14(2):159-65. PubMed ID: 17942516
[TBL] [Abstract][Full Text] [Related]
6. Increased nitric oxide products in CSF in primary progressive MS may reflect brain atrophy.
Peltola J; Ukkonen M; Moilanen E; Elovaara I
Neurology; 2001 Sep; 57(5):895-6. PubMed ID: 11552025
[TBL] [Abstract][Full Text] [Related]
7. Serum uric acid, dehydroepiandrosterone sulphate, and apolipoprotein E genotype in benign vs. progressive multiple sclerosis.
Ramsaransing GS; Heersema DJ; De Keyser J
Eur J Neurol; 2005 Jul; 12(7):514-8. PubMed ID: 15958090
[TBL] [Abstract][Full Text] [Related]
8. Plasma homocysteine levels in multiple sclerosis.
Ramsaransing GS; Fokkema MR; Teelken A; Arutjunyan AV; Koch M; De Keyser J
J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):189-92. PubMed ID: 16421120
[TBL] [Abstract][Full Text] [Related]
9. Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
Haghikia A; Kayacelebi AA; Beckmann B; Hanff E; Gold R; Haghikia A; Tsikas D
Amino Acids; 2015 Sep; 47(9):1837-45. PubMed ID: 26055922
[TBL] [Abstract][Full Text] [Related]
10. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis.
Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Caggiula M; Mirabella M; Tonali PA; Batocchi AP
Cytokine; 2008 Oct; 44(1):22-5. PubMed ID: 18793860
[TBL] [Abstract][Full Text] [Related]
11. Cytokine profile, Foxp3 and nuclear factor-kB ligand levels in multiple sclerosis subtypes.
Alatab S; Maghbooli Z; Hossein-Nezhad A; Khosrofar M; Mokhtari F
Minerva Med; 2011 Dec; 102(6):461-8. PubMed ID: 22193377
[TBL] [Abstract][Full Text] [Related]
12. Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
Malhotra S; Fissolo N; Tintoré M; Wing AC; Castilló J; Vidal-Jordana A; Montalban X; Comabella M
J Neuroinflammation; 2015 Mar; 12():48. PubMed ID: 25879961
[TBL] [Abstract][Full Text] [Related]
13. Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.
Cantó E; Reverter F; Morcillo-Suárez C; Matesanz F; Fernández O; Izquierdo G; Vandenbroeck K; Rodríguez-Antigüedad A; Urcelay E; Arroyo R; Otaegui D; Olascoaga J; Saiz A; Navarro A; Sanchez A; Domínguez C; Caminero A; Horga A; Tintoré M; Montalban X; Comabella M
Mult Scler; 2012 Jul; 18(7):983-90. PubMed ID: 22183936
[TBL] [Abstract][Full Text] [Related]
14. Demyelinating lesions in the cervical cord in multiple sclerosis 10 years after onset of the disease. Correlation between MRI parameters and clinical course.
Bonek R; Orlicka K; Maciejek Z
Neurol Neurochir Pol; 2007; 41(3):229-33. PubMed ID: 17629816
[TBL] [Abstract][Full Text] [Related]
15. Increased interleukin-1 production by peripheral blood mononuclear cells in patients with multiple sclerosis.
Matsuda M; Tsukada N; Miyagi K; Yanagisawa N
J Neurol Sci; 1991 Mar; 102(1):100-4. PubMed ID: 1856726
[TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of some inflammatory markers in patients with multiple sclerosis.
Uysal S; Meriç Yilmaz F; Boğdaycioğlu N; Mungan Öztürk S; Ak F
Minerva Med; 2014 Jun; 105(3):229-35. PubMed ID: 24988088
[TBL] [Abstract][Full Text] [Related]
17. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.
Booth DR; Arthur AT; Teutsch SM; Bye C; Rubio J; Armati PJ; Pollard JD; Heard RN; Stewart GJ;
J Mol Med (Berl); 2005 Oct; 83(10):822-30. PubMed ID: 16075257
[TBL] [Abstract][Full Text] [Related]
18. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis.
Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA
Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029
[TBL] [Abstract][Full Text] [Related]
19. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease.
Killestein J; Den Drijver BF; Van der Graaff WL; Uitdehaag BM; Polman CH; Van Lier RA
Mult Scler; 2001 Jun; 7(3):145-50. PubMed ID: 11475436
[TBL] [Abstract][Full Text] [Related]
20. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis.
Rejdak K; Eikelenboom MJ; Petzold A; Thompson EJ; Stelmasiak Z; Lazeron RH; Barkhof F; Polman CH; Uitdehaag BM; Giovannoni G
Neurology; 2004 Oct; 63(8):1439-45. PubMed ID: 15505162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
